JPMorgan Chase & Co’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-21,029
Closed -$47.9K 6565
2024
Q2
$47.9K Sell
21,029
-33,605
-62% -$76.6K ﹤0.01% 4919
2024
Q1
$236K Buy
54,634
+54,384
+21,754% +$235K ﹤0.01% 4376
2023
Q4
$763 Sell
250
-9,110
-97% -$27.8K ﹤0.01% 5835
2023
Q3
$13.5K Sell
9,360
-2,106,513
-100% -$3.03M ﹤0.01% 5245
2023
Q2
$5.27M Sell
2,115,873
-33,653
-2% -$83.8K ﹤0.01% 2456
2023
Q1
$5.76M Buy
2,149,526
+113,904
+6% +$305K ﹤0.01% 2351
2022
Q4
$11.1M Sell
2,035,622
-8,151
-0.4% -$44.3K ﹤0.01% 1844
2022
Q3
$25.5M Sell
2,043,773
-85,676
-4% -$1.07M ﹤0.01% 1253
2022
Q2
$10.5M Buy
2,129,449
+31,696
+2% +$157K ﹤0.01% 1850
2022
Q1
$15.9M Sell
2,097,753
-45,931
-2% -$349K ﹤0.01% 1706
2021
Q4
$21.9M Sell
2,143,684
-95,995
-4% -$980K ﹤0.01% 1529
2021
Q3
$30.1M Buy
2,239,679
+363,519
+19% +$4.88M ﹤0.01% 1311
2021
Q2
$41.2M Buy
1,876,160
+48,271
+3% +$1.06M ﹤0.01% 1192
2021
Q1
$44M Buy
1,827,889
+159,467
+10% +$3.84M 0.01% 1121
2020
Q4
$30M Buy
1,668,422
+4,241
+0.3% +$76.3K ﹤0.01% 1200
2020
Q3
$19.8M Sell
1,664,181
-381,527
-19% -$4.55M ﹤0.01% 1328
2020
Q2
$49.6M Buy
2,045,708
+349,889
+21% +$8.49M 0.01% 829
2020
Q1
$18.7M Buy
1,695,819
+26,680
+2% +$294K ﹤0.01% 1186
2019
Q4
$44.1M Buy
1,669,139
+423,954
+34% +$11.2M 0.01% 921
2019
Q3
$28.4M Sell
1,245,185
-183,953
-13% -$4.19M 0.01% 1155
2019
Q2
$44.4M Buy
1,429,138
+310,614
+28% +$9.66M 0.01% 924
2019
Q1
$18.6M Buy
1,118,524
+89,450
+9% +$1.48M ﹤0.01% 1382
2018
Q4
$19.7M Buy
1,029,074
+498,095
+94% +$9.54M ﹤0.01% 1278
2018
Q3
$27.8M Buy
530,979
+75,690
+17% +$3.96M 0.01% 1232
2018
Q2
$19.8M Buy
455,289
+233,734
+105% +$10.2M ﹤0.01% 1391
2018
Q1
$8.21M Buy
221,555
+205,881
+1,314% +$7.63M ﹤0.01% 1886
2017
Q4
$311K Buy
+15,674
New +$311K ﹤0.01% 3527